Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Estrella Immunopharma Inc - Warrants (29/09/2028) (ESLAW)

Annual Return

Over the past 3 years, ESLAW has had an average annual return of +14.43%, underperforming the benchmark SPY, which returned +22.45% annual.

Since Sep 14, 2021, ESLAW has had an average annual return of -19.41%, underperforming the benchmark SPY, which returned +13.42% annual.

202620252024202320222021
+159.97%-45.59%+206.48%-42.31%-89.60%+38.89%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+20.01%+26.63%-1.42%+71.12%+5.22%-3.63%+159.97%
2025-43.44%+15.44%+28.49%+14.75%-59.64%+32.96%-5.00%-20.19%+43.90%+131.83%-17.57%-49.49%-45.59%
2024+0.72%+32.42%+65.98%+4.07%-1.72%+1.64%+44.91%+0%-35.71%+42.95%-0.98%+0.99%+206.48%
2023+1.94%+28.12%+50.69%-23.86%-31.98%+4.76%+188.20%-22.75%+94.26%-67.01%-55.55%-14.83%-42.31%
2022-42.00%-27.59%+6.96%-6.51%-24.81%+59.78%-32.62%+27.89%-68.77%+138.92%-56.86%-25.72%-89.60%
2021+13.78%+17.21%+13.10%-7.92%+38.89%

Drawdown analysis of Estrella Immunopharma Inc - Warrants (29/09/2028) (ESLAW)

The maximum drawdown for the ESLAW was -96.11%, occurring on Jan 25, 2023. This drawdown has not yet recovered.

The current ESLAW drawdown is -76.58%.

Since Sep 14, 2021 ESLAW has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-96.11%Nov 3, 2021307Jan 25, 2023OngoingOngoingOngoing
-12.09%Oct 25, 20213Oct 28, 20212Nov 1, 20215
-4.70%Sep 23, 20215Sep 30, 20215Oct 7, 202110
-4.65%Oct 7, 20219Oct 20, 20212Oct 22, 202111
-3.60%Nov 1, 20211Nov 2, 20211Nov 3, 20212
-2.38%Sep 16, 20212Sep 20, 20213Sep 23, 20215